Form 4: Sotera Health Director Constantine Mihas Acquires 19,132 Restricted Stock Units

Sotera Health Co. Director Constantine S. Mihas has acquired 19,132 restricted stock units (RSUs) as part of his compensation, increasing his beneficial ownership in the company.

Summary

• Constantine S. Mihas, a Director of Sotera Health Co (SHC), acquired 19,132 restricted stock units (RSUs) on May 22, 2025.
• These RSUs were granted at a price of $0 per unit, consistent with compensation grants.
• The RSUs will vest in full on the earlier of the first anniversary of the grant date or the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to Mr. Mihas's continued service as a non-employee director.
• Following this transaction, Mr. Mihas's beneficial ownership in Sotera Health Co. totals 80,781 securities, which includes the newly acquired 19,132 RSUs and 61,649 shares of Common Stock.
• The grant was made pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan.

Sentiment

Score: 6

Explanation: The grant of restricted stock units to a director is a routine compensation event, indicating continued alignment of interests between the director and shareholders, which is generally viewed as a neutral to slightly positive development.

Positives

• The acquisition of restricted stock units by a director aligns their interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
• This transaction represents a routine compensation grant, indicating continued commitment and involvement of a key board member.

Future Outlook

The acquired restricted stock units are subject to future vesting conditions, which will result in the issuance of common stock to the director upon fulfillment of service requirements, either on the first anniversary of the grant date or prior to the next annual shareholders meeting.

Industry Context

This Form 4 filing details a routine insider transaction, specifically the grant of equity compensation to a non-employee director. Such grants are a common practice across industries to align the interests of board members with long-term shareholder value and are typically disclosed via Form 4 filings.

Corporate Governance

Related Party Transactions

• The grant of restricted stock units to Constantine S. Mihas, a director, constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The transaction aligns the director's financial interests with the company's stock performance, potentially encouraging decisions that enhance shareholder value.
• Management: This is a standard compensation mechanism for non-employee directors, reflecting established corporate governance practices.

Next Steps

• Vesting of the 19,132 restricted stock units on the earlier of May 22, 2026, or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on continued service.

Key Dates

Recommendation

Keywords

Sotera Health, SHC, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership